
Overview
Background
Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.
She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.
In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).
On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.
Research Interests
Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.
Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.
Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.
Christine’s current projects include:
- Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
- Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
- Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
- Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
- Improving gentamycin dosing in paediatric oncology patients
- Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
- Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
- Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis
Projects currently available for interested research higher degree students include:
- Dose optimisation of busulfan in paediatric bone marrow transplant recipients
- Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
- Examining Bayesian forecasting methods to predict immunosuppressant exposure
- Examining the international use of immunosuppressant and anti-rheumatic drugs
- Examining the influence of plasma exchange on immunosuppressant drug exposure
Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.
Teaching interests
Co-ordinates:
- PHRM3052- Biological Fate of Drugs
Teaches in:
- PHRM3052- Biological Fate of Drugs
- PHRM3011- Quality Use of Medicines
Availability
- Dr Christine Staatz is:
- Available for supervision
Fields of research
Qualifications
- Bachelor, The University of Queensland
- Bachelor (Honours) of Pharmacy, The University of Queensland
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Christine Staatz’s works on UQ eSpace
2006
Conference Publication
Conditional weighted residuals, an improved model diagnostic for the FO/FOCE methods
Hooker, A., Staatz, C E and Karlsson, M. (2006). Conditional weighted residuals, an improved model diagnostic for the FO/FOCE methods. Annual Meeting of the Population Approach Group in Europe, Brugge Belgium, 14-16 June 2006. Belgium: Population Approach Group in Europe.
2006
Journal Article
Population pharmacokinetic modeling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery
Staatz, Christine E., Byrne, Colette and Thomson, Alison H. (2006). Population pharmacokinetic modeling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery. British Journal of Clinical Pharmacology, 61 (2), 164-176. doi: 10.1111/j.1365-2125.2005.02547.x
2006
Conference Publication
Predictors of new onset diabetes after renal transplantation
Joss, N., Staatz, C., Thomson, A. and Jardine, A. G. (2006). Predictors of new onset diabetes after renal transplantation. Annual Meeting of the Scottish Cardiac Society, Turnberry, Scotland, November 2006. GLASGOW: SCOTTISH MEDICAL JOURNAL.
2006
Journal Article
Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2006). Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients. Journal of Clinical Pharmacy And Therapeutics, 31 (1), 17-25. doi: 10.1111/j.1365-2710.2006.00697.x
2006
Conference Publication
Predictors of new onset diabetes after renal transplantation
Joss, N., Staatz, C. E., Thomson, A. and Jardine, A. G. (2006). Predictors of new onset diabetes after renal transplantation. Annual Meeting of the Scottish Cardiac Society, Turnberry Hotel, Ayrshire Scotland, November 2005. Scotland: Scottish Renal Association.
2005
Journal Article
Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation
Staatz, Christine E., Duffull, Stephen B., Kiberd, Bryce, Fraser, Albert D. and Tett, Susan E. (2005). Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. European Journal of Clinical Pharmacology, 61 (7), 507-516. doi: 10.1007/s00228-005-0927-4
2005
Conference Publication
Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiac surgery
Staatz, CE, Byrne, C and Thomson, AH (2005). Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiac surgery. 9th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Louisville KY, APR 23-28, 2005. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00007691-200504000-00079
2005
Journal Article
Pharmacokinetic considerations relating to tacrolimus dosing in the elderly
Staatz, C. E. and Tett, S. E. (2005). Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs & Aging, 22 (7), 541-557. doi: 10.2165/00002512-200522070-00001
2005
Journal Article
Tacrolimus in patients with rheumatoid arthritis - A viewpoint by Christine Staatz
Staatz, C (2005). Tacrolimus in patients with rheumatoid arthritis - A viewpoint by Christine Staatz. Drugs, 65 (7), 1003-1003.
2004
Journal Article
A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation
Staatz, Christine E., Taylor, Paul J., Lynch, Stephen V. and Tett, Susan E. (2004). A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transplantation, 10 (4), 506-512. doi: 10.1002/lt.20065
2004
Conference Publication
Evaluation of a population pharmacokinetic model for gentamicin in patients with unstable renal function following cardiac surgery
Staatz, C. E., Byrne, C. and Thomson, A. H. (2004). Evaluation of a population pharmacokinetic model for gentamicin in patients with unstable renal function following cardiac surgery. PKUK conference, Belfast, Ireland, November 2004.
2004
Journal Article
Sampling times for monitoring tacrolimus in stable adult liver transplant recipients
Dansirikul, C, Staatz, CE, Duffull, SB, Taylor, PJ, Lynch, SV and Tett, SE (2004). Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Therapeutic Drug Monitoring, 26 (6), 593-599. doi: 10.1097/00007691-200412000-00003
2004
Journal Article
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
Staatz, C. E. and Tett, S. E. (2004). Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clinical Pharmacokinetics, 43 (10), 623-653. doi: 10.2165/00003088-200443100-00001
2003
Journal Article
Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients
Willis, Charlene, Staatz, Christine E. and Tett, Susan E. (2003). Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Therapeutic Drug Monitoring, 25 (2), 158-166. doi: 10.1097/00007691-200304000-00004
2003
Conference Publication
Pharmacodynamic investigations of tacrolimus in liver transplantation
Staatz, C. E., Dansirikul, C., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2003). Pharmacodynamic investigations of tacrolimus in liver transplantation. TSANZ 21st Annual Scientific Meeting, Canberra, 9-11 April 2003. Canberra: TSANZ. doi: 10.1046/j.1440-1711.2003.00812.x
2003
Conference Publication
Pharmacodynamics of tacrolimus in pediatric liver transplantation
Staatz, C. E., TaylorPJ, LynchSV, TettSE, SSoldin and FSjoeqvist (2003). Pharmacodynamics of tacrolimus in pediatric liver transplantation. 8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Basel, Switzerland, 7-11 September, 2003. New York: Lippincott-Raven.
2003
Conference Publication
Detecting drug interactions associated with tacrolimus
Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Detecting drug interactions associated with tacrolimus. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:
2003
Journal Article
Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation
Staatz, Christine E., Willis, Charlene, Taylor, Paul J, Lynch, Stephen V. and Tett, Susan E. (2003). Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transplantation, 9 (2), 130-137. doi: 10.1053/jlts.2003.50023
2003
Conference Publication
Limited sampling strategies for monitoring tacrolimus in liver transplant recipients
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Limited sampling strategies for monitoring tacrolimus in liver transplant recipients. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:
2002
Journal Article
Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus
Staatz, Christine E. and Tett, Susan E. (2002). Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. European Journal of Clinical Pharmacology, 58 (9), 597-605. doi: 10.1007/s00228-002-0517-7
Funding
Current funding
Supervision
Availability
- Dr Christine Staatz is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Improving patient centred outcomes in kidney transplant recipients
Principal Advisor
Other advisors: Dr Andrew Mallett
-
Doctor Philosophy
To investigate the pharmacotherapy management of the bariatric surgery patient and the impact of the pharmacist in the multidisciplinary team
Principal Advisor
Other advisors: Dr Meng-Wong Taing
-
Doctor Philosophy
Exploring free plasma tacrolimus and mycophenolic acid measurements and defining a therapeutic target range for therapeutic drug monitoring
Principal Advisor
Other advisors: Dr Meng-Wong Taing
-
Doctor Philosophy
The IMPEDE-PKD Clinical Trial - Investigating the repurposing of metformin in ADPKD
Associate Advisor
Other advisors: Professor David Johnson, Professor Carmel Hawley, Dr Andrew Mallett, Associate Professor Andrea Viecelli
-
Doctor Philosophy
Establishing the Role of Metformin for Autosomal Dominant Polycystic Kidney Disease Management
Associate Advisor
Other advisors: Professor David Johnson, Professor Carmel Hawley, Associate Professor Andrea Viecelli, Dr Andrew Mallett
Completed supervision
-
2024
Doctor Philosophy
Improving patient centred outcomes in kidney transplant recipients
Principal Advisor
Other advisors: Dr Andrew Mallett
-
2023
Doctor Philosophy
Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Children: Once daily administration
Principal Advisor
-
2022
Doctor Philosophy
Optimising immunosuppressant medicines in elderly kidney transplant recipients
Principal Advisor
-
2021
Doctor Philosophy
Evaluating Prediction Methods for Estimating Tacrolimus, Mycophenolate and Prednisolone Exposure Following Adult Kidney Transplantation
Principal Advisor
Other advisors: Emeritus Professor Sue Tett
-
2016
Doctor Philosophy
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
Principal Advisor
Other advisors: Emeritus Professor Sue Tett
-
2016
Doctor Philosophy
Optimizing beta-lactam antibiotic dosing in critically ill patients: Prolonged infusion versus intermittent bolus administration
Associate Advisor
Other advisors: Professor Jeffrey Lipman, Professor Jason Roberts
-
2012
Doctor Philosophy
Pharmacokinetic, Pharmacogenetic and Pharmacodynamic Monitoring of Immunosuppressive Therapy in Adult Kidney Transplant Recipients
Associate Advisor
-
2018
Doctor Philosophy
Optimising gentamicin therapy in paediatric oncology patients
Joint Principal Advisor
-
2017
Doctor Philosophy
The impact of increasing patient weight on the dosing of high-dose methotrexate chemotherapy in aggressive non-Hodgkin lymphoma
Joint Principal Advisor
Media
Enquiries
For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team: